Clinical Trial Update: MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MB07133 in unresectable hepatocellular carcinoma is reported, with safety and effect/tolerance considerations noted; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MB07133

Snippet

Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Conditions: Safety Issues, Effect of Drug | Phase 2 | Status: UNKNOWN